A. Cross

Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas

M. Dalili, K. Thomas, Gemma Morgan, 2022, BMC Public Health.

Evolution of long-term hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study

A. Mentzer, S. Faustini, A. Angyal, 2022, medRxiv.

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

P. Klenerman, S. Rowland-Jones, M. Haniffa, 2021, The Lancet Microbe.

Inhibition of the tissue factor/factor VIIa complex — Lead optimisation using combinatorial chemistry

M. Bradley, P. Roussel, A. Cross, 1999 .

Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs.

B. Singer, A. Cross, 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Rosalind J Wright, P. Klenerman, S. Rowland-Jones, 2021, Cell.

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

P. Klenerman, S. Rowland-Jones, G. Screaton, 2023, Med.

Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine

P. Klenerman, S. Rowland-Jones, G. Screaton, 2021, SSRN Electronic Journal.